Boston, MA -- (SBWIRE) -- 12/06/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: 22nd Century Group Inc(OTCBB:XXII), Athersys, Inc.(NASDAQ:ATHX), XOMA Corp(NASDAQ:XOMA), Cemex SAB de CV (ADR)(NYSE:CX).
22nd Century Group Inc(OTCBB:XXII) opened its shares at the price of $1.48 for the day. Its closing price was $1.45 after losing -2.03% for the day. The company traded with the total volume of 455,165shares, while its average trading volume remained 247,176 shares. The beta of XXII stands at -4.22. 22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. It develops smoking cessation products for smokers who are unable or unwilling to quit smoking; and modified risk tobacco products that reduce exposure to certain tobacco smoke toxins compared to conventional cigarettes.
Has XXII Found The Bottom and Ready To Move Up? Find Out Here
Athersys, Inc.(NASDAQ:ATHX) percentage change surged +0.91% to close at $2.22 with the total traded volume of 1.05 million shares, and average volume of 630,235. The 52 week range of the stock remained $0.98 - $2.42, while its day lowest price was $2.21 and it hit its day highest price at $2.26. Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being evaluated in two ongoing Phase II clinical trials.
For How Long ATHX Gloss will Attract Investors? Find out via this report
XOMA Corp(NASDAQ:XOMA) started its trading session with the price of $5.84 and closed at $6.01 by losing -1.64%. XOMA stocks traded with total volume of 2.99 million shares, while the average trading volume remained 1.85 million shares. The beta of XOMA stands at 2.39. Day range of the stock was $5.81 -$6.24. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta).
Will XOMA Continue To Move Higher? Find Out Here
Cemex SAB de CV (ADR)(NYSE:CX) ended its day with the loss of -1.35% and closed at the price of $11.00 after opening at $11.03. Stock traded during its last trading session with the total volume of 11.53 million shares, as compared to its average volume of 13.06 million shares. Cemex SAB de CV (CEMEX) is a Mexico-based company principally engaged, through its subsidiaries, in the cement manufacturing. The Company produces, distributes and sells cement, clinker, ready-mix concrete, aggregates, concrete blocks, roof tiles, concrete pipes and related building materials in numerous countries worldwide.
Will CX Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)